Lymphokine-Activated Killer Cells Can Kill Target Cells Not only by Early Killing but Also by Late Killing, and the Late Killing Level Against Autotumor Cell Line

Oncology Research

Volumn 13, Issue 4, 2002, Pages 235-241

  Komatsu, Fumio ^a   Ishiguro, Kiyomi ^a  

^a KAGAWA NUTRITION UNIVERSITY   (Japan)

Author keywords

Autotumor cell line; Cell cell adhesion killing; Early killing; LAK cells; Late killing; Lsosome

Indexed keywords

3 METHYLADENINE; LYMPHOKINE;

ADULT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PATIENT; CASE REPORT; CELL ADHESION; CELL DEATH; CELL FUNCTION; CELL TYPE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; LYSOSOME; MALE; PRIORITY JOURNAL; CELL CULTURE; COMPARATIVE STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MIDDLE AGED; PATHOLOGY;

CELL DEATH; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED;

EID: 0141993296     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. + natural killer cells: Role in cell activation and regulation of cytolytic function. J. Exp. Med. 171:695-714; 1990.
2. Vitale, M.; Sivori, S.; Pende, D.; Moretta, L., Moretta, A. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. Proc. Natl. Acad. Sci. USA 92: 3536-3540; 1995.
3. Komatsu, F.; Masuda, T. Cell-cell adhesion-independent killing due to lymphokine-activated killer cells against glioblastoma cell lines. Oncol. Res. 12:371-381; 2001.
4. + peripheral blood lymphocytes. Clin. Immunol. Immunopathol. 77:75-81; 1995.
5. Wyllie, A. H.; Kerr, J. F. R.; Currie, A. R. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68:251-306; 1980.
6. Kane, D. J.; Ord, T.; Anton, R.; Bredesen, D. E. Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40:269-275; 1995.
7. Schwarts, L. M.; Smith, S. W.; Jones, M. E.; Osborne, B. A. Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA 90:980-984; 1993.
8. Clarke, P. G. H. Developmental cell death: Morphological diversity and multiple mechanisms. Anat. Embryol. 181:195-213; 1990.
9. Zakeri, Z.; Bursch, W.; Tenniswood, M.; Lockshin, R. A. Cell death: Programmed, apoptosis, necrosis or other? Cell Death Differ. 2:87-96; 1995.
10. Kitanaka, C.; Kuchino, Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 6:508-515: 1999.
11. +-ATPase, on CTL-mediated cytotoxicity. J. Immunol. 153:3938-3947; 1994.
12. Seglen, P. O.; Gordon, P. B. 3-Methyladenine: Specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. USA 79:1889-1892; 1982.
13. Kumar, S.; Lavin, M. F. The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ. 3:255-268; 1996.
14. Quignon, F.; De Bels, F.; Koken, M.; Feunteun, J.; Ameisen, J-C.; De The, H. PML induces a novel caspase-independent death process. Nat. Genet. 20:259-265; 1998.
15. Xiang, J.; Chao, D. T.; Korsmeyer, S. J. Bax-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93:14559-14563; 1996.
16. Deas, O.; Dumon, C.; MacFarlane, M.; Rouleau, M.; Hebib, C.; Harper, F.; Hirsh, F.; Charpentier, B.; Cohen, G. M.; Senik, A. Caspase-independent cell death induced by anti-CD2 or staurosporin in activated human peripheral T lymphocytes. J. Immunol. 161:3375-3383; 1998.
17. Amarante-Mendes, G. P.; Finucane, D. M.; Martin, S. J.; Cotter, T. G.; Salvesen, G. S.; Green, D. R. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Differ. 5:298-306; 1998.
18. Vercammen, D.; Beyaert, R.; Denecker, G.; Goossens, V.; Van Loo, G.; Declercq, W.; Grooten, J.; Fiers, W.; Vandenabeele, P. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187: 1477-1485; 1998.
19. Chi, S.; Kitanaka, C.; Noguchi, K.; Mochizuki, T.; Nagashima, Y.; Shirouzu, M.; Fujita, H.; Yoshida, M.; Chen, W.; Asai, A.; Himeno, M.; Yokoyama, S.; Kuchino, Y. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene 18:2281-2290; 1999.
20. Franke, T. F.; Kaplan, D. R.; Cantley, L. C. PI3K: Downstream AKTion blocks apoptosis. Cell 88:435-437; 1997.
21. Rutenburg, A. M.; Seligman, A. M. The histochemical demonstration of acid phosphatase by a post-incubation coupling technique. J. Histochem. 3:455-470; 1955.